BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Waissbluth S, Daniel SJ. Cisplatin-induced ototoxicity: transporters playing a role in cisplatin toxicity. Hear Res. 2013;299:37-45. [PMID: 23467171 DOI: 10.1016/j.heares.2013.02.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Yu D, Gu J, Chen Y, Kang W, Wang X, Wu H. Current Strategies to Combat Cisplatin-Induced Ototoxicity. Front Pharmacol 2020;11:999. [PMID: 32719605 DOI: 10.3389/fphar.2020.00999] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
2 Wang D, Shi S, Ren T, Zhang Y, Guo P, Wang J, Wang W. U0126 pretreatment inhibits cisplatin-induced apoptosis and autophagy in HEI-OC1 cells and cochlear hair cells. Toxicol Appl Pharmacol 2021;415:115447. [PMID: 33577918 DOI: 10.1016/j.taap.2021.115447] [Reference Citation Analysis]
3 Naples JG. Calcium-channel blockers as therapeutic agents for acquired sensorineural hearing loss. Med Hypotheses 2017;104:121-5. [PMID: 28673569 DOI: 10.1016/j.mehy.2017.05.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Prayuenyong P, Baguley DM, Kros CJ, Steyger PS. Preferential Cochleotoxicity of Cisplatin. Front Neurosci 2021;15:695268. [PMID: 34381329 DOI: 10.3389/fnins.2021.695268] [Reference Citation Analysis]
5 Li Y, Li A, Wu J, He Y, Yu H, Chai R, Li H. MiR-182-5p protects inner ear hair cells from cisplatin-induced apoptosis by inhibiting FOXO3a. Cell Death Dis 2016;7:e2362. [PMID: 27607577 DOI: 10.1038/cddis.2016.246] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
6 Naples JG, Parham K. Cisplatin-Induced Ototoxicity and the Effects of Intratympanic Diltiazem in a Mouse Model. Otolaryngol Head Neck Surg 2016;154:144-9. [DOI: 10.1177/0194599815606704] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
7 Nicholas BD, Francis S, Wagner EL, Zhang S, Shin JB. Protein Synthesis Inhibition and Activation of the c-Jun N-Terminal Kinase Are Potential Contributors to Cisplatin Ototoxicity. Front Cell Neurosci 2017;11:303. [PMID: 29033791 DOI: 10.3389/fncel.2017.00303] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Comsa E, Nguyen KA, Loghin F, Boumendjel A, Peuchmaur M, Andrieu T, Falson P. Ovarian cancer cells cisplatin sensitization agents selected by mass cytometry target ABCC2 inhibition. Future Med Chem 2018;10:1349-60. [PMID: 29848100 DOI: 10.4155/fmc-2017-0308] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
9 Naples JG, Ruckenstein MJ, Singh J, Cox BC, Li D. Intratympanic Diltiazem-Chitosan Hydrogel as an Otoprotectant Against Cisplatin-Induced Ototoxicity in a Mouse Model. Otol Neurotol 2020;41:115-22. [PMID: 31746818 DOI: 10.1097/MAO.0000000000002417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Yu X, Man R, Li Y, Yang Q, Li H, Yang H, Bai X, Yin H, Li J, Wang H. Paeoniflorin protects spiral ganglion neurons from cisplatin-induced ototoxicity: Possible relation to PINK1/BAD pathway. J Cell Mol Med 2019;23:5098-107. [PMID: 31207045 DOI: 10.1111/jcmm.14379] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
11 Chen Q, Liu X, Luo Z, Wang S, Lin J, Xie Z, Li M, Li C, Cao H, Huang Q, Mao J, Xu B. Chloride channel-3 mediates multidrug resistance of cancer by upregulating P-glycoprotein expression. J Cell Physiol 2019;234:6611-23. [PMID: 30230544 DOI: 10.1002/jcp.27402] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
12 Monroe JD, Hodzic D, Millay MH, Patty BG, Smith ME. Anti-Cancer and Ototoxicity Characteristics of the Curcuminoids, CLEFMA and EF24, in Combination with Cisplatin. Molecules 2019;24:E3889. [PMID: 31671767 DOI: 10.3390/molecules24213889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang CQ, Zheng XT, Chen XF, Jiang H, Huang J, Jiang Y, Hu SS, Huang XR, Liu SY, Gong QH, Feng JH, Xiao X, Li XF, Xiao Z. The Optimal Adjuvant Strategy of Aidi Injection With Gemcitabine and Cisplatin in Advanced Non-small Cell Lung Cancer: A Meta-analysis of 70 Randomized Controlled Trials. Front Pharmacol 2021;12:582447. [PMID: 34122057 DOI: 10.3389/fphar.2021.582447] [Reference Citation Analysis]
14 Zeng FL, Xiao Z, Wang CQ, Jiang Y, Shan JL, Hu SS, Huang XR, Tang YH, Yao XS, Zhang T, Zeng XT, Feng JH, Xiao X. Clinical efficacy and safety of synthetic thymic peptides with chemotherapy for non-small cell lung cancer in China: A systematic review and meta-analysis of 27 randomized controlled trials following the PRISMA guidelines. Int Immunopharmacol 2019;75:105747. [PMID: 31326719 DOI: 10.1016/j.intimp.2019.105747] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Lou JS, Xia YT, Wang HY, Kong XP, Yao P, Dong TTX, Zhou ZY, Tsim KWK. The WT1/MVP-Mediated Stabilization on mTOR/AKT Axis Enhances the Effects of Cisplatin in Non-small Cell Lung Cancer by a Reformulated Yu Ping Feng San Herbal Preparation. Front Pharmacol 2018;9:853. [PMID: 30131696 DOI: 10.3389/fphar.2018.00853] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
16 Quintanilha JCF, Saavedra KF, Visacri MB, Moriel P, Salazar LA. Role of epigenetic mechanisms in cisplatin-induced toxicity. Crit Rev Oncol Hematol 2019;137:131-42. [PMID: 31014509 DOI: 10.1016/j.critrevonc.2019.03.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
17 Liu W, Xu X, Fan Z, Sun G, Han Y, Zhang D, Xu L, Wang M, Wang X, Zhang S, Tang M, Li J, Chai R, Wang H. Wnt Signaling Activates TP53-Induced Glycolysis and Apoptosis Regulator and Protects Against Cisplatin-Induced Spiral Ganglion Neuron Damage in the Mouse Cochlea. Antioxid Redox Signal 2019;30:1389-410. [PMID: 29587485 DOI: 10.1089/ars.2017.7288] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 20.0] [Reference Citation Analysis]
18 Abdelsameea AA, Kabil SL. Mitigation of cisplatin-induced peripheral neuropathy by canagliflozin in rats. Naunyn Schmiedebergs Arch Pharmacol 2018;391:945-52. [PMID: 29862426 DOI: 10.1007/s00210-018-1521-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
19 Anderson JT, Huang KM, Lustberg MB, Sparreboom A, Hu S. Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions. Rev Physiol Biochem Pharmacol 2020. [PMID: 32761456 DOI: 10.1007/112_2020_30] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Vila PM, Lieu JE. Asymmetric and unilateral hearing loss in children. Cell Tissue Res 2015;361:271-8. [PMID: 26004144 DOI: 10.1007/s00441-015-2208-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
21 Ye R, Liu J, Jia Z, Wang H, Wang Y, Sun W, Wu X, Zhao Z, Niu B, Li X, Dai G, Li J. Adenosine Triphosphate (ATP) Inhibits Voltage-Sensitive Potassium Currents in Isolated Hensen's Cells and Nifedipine Protects Against Noise-Induced Hearing Loss in Guinea Pigs. Med Sci Monit 2016;22:2006-12. [PMID: 27292522 DOI: 10.12659/msm.898150] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Liu Y, Wu H, Zhang F, Yang J, He J. Resveratrol upregulates miR-455-5p to antagonize cisplatin ototoxicity via modulating the PTEN-PI3K-AKT axis. Biochem Cell Biol 2021;99:385-95. [PMID: 34077275 DOI: 10.1139/bcb-2020-0459] [Reference Citation Analysis]
23 Li J, O W, Li W, Jiang ZG, Ghanbari HA. Oxidative stress and neurodegenerative disorders. Int J Mol Sci 2013;14:24438-75. [PMID: 24351827 DOI: 10.3390/ijms141224438] [Cited by in Crossref: 204] [Cited by in F6Publishing: 154] [Article Influence: 25.5] [Reference Citation Analysis]
24 Zhang P, Chen JQ, Huang WQ, Li W, Huang Y, Zhang ZJ, Xu FG. Renal Medulla is More Sensitive to Cisplatin than Cortex Revealed by Untargeted Mass Spectrometry-Based Metabolomics in Rats. Sci Rep 2017;7:44804. [PMID: 28300186 DOI: 10.1038/srep44804] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
25 Ma W, Hu J, Cheng Y, Wang J, Zhang X, Xu M. Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt–Nrf2–HO-1 signaling and reduction of NADPH oxidase. Cancer Chemother Pharmacol 2015;75:949-59. [DOI: 10.1007/s00280-015-2716-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
26 Xiao Z, Jiang Y, Wang CQ, Hu SS, Huang XR, Chen XF, Huang J, Shan LJ, Tang YH, Wang YH, Gong QH, Feng JH, Xiao X, Li XF. Clinical efficacy and safety of aidi injection combination with vinorelbine and cisplatin for advanced non-small-cell lung carcinoma: A systematic review and meta-analysis of 54 randomized controlled trials. Pharmacol Res 2020;153:104637. [PMID: 31935454 DOI: 10.1016/j.phrs.2020.104637] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
27 Liu X, Li M, Smyth H, Zhang F. Otic drug delivery systems: formulation principles and recent developments. Drug Dev Ind Pharm 2018;44:1395-408. [PMID: 29659300 DOI: 10.1080/03639045.2018.1464022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
28 Pelosi C, Saitta F, Zerino C, Canil G, Biver T, Pratesi A, Duce C, Fessas D, Gabbiani C, Tiné MR. Thermodynamic Evaluation of the Interactions between Anticancer Pt(II) Complexes and Model Proteins. Molecules 2021;26:2376. [PMID: 33921819 DOI: 10.3390/molecules26082376] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Nan B, Gu X, Huang X. The Role of the Reactive Oxygen Species Scavenger Agent, Astaxanthin, in the Protection of Cisplatin-Treated Patients Against Hearing Loss. Drug Des Devel Ther 2019;13:4291-303. [PMID: 31908415 DOI: 10.2147/DDDT.S212313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
30 Rybak LP, Mukherjea D, Ramkumar V. Mechanisms of Cisplatin-Induced Ototoxicity and Prevention. Semin Hear 2019;40:197-204. [PMID: 31036996 DOI: 10.1055/s-0039-1684048] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 15.5] [Reference Citation Analysis]
31 Qi L, Luo Q, Zhang Y, Jia F, Zhao Y, Wang F. Advances in Toxicological Research of the Anticancer Drug Cisplatin. Chem Res Toxicol 2019;32:1469-86. [PMID: 31353895 DOI: 10.1021/acs.chemrestox.9b00204] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 19.5] [Reference Citation Analysis]
32 Kim SJ, Kim HS, Seo YR. Understanding of ROS-Inducing Strategy in Anticancer Therapy. Oxid Med Cell Longev 2019;2019:5381692. [PMID: 31929855 DOI: 10.1155/2019/5381692] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 27.5] [Reference Citation Analysis]
33 Tchounwou PB, Dasari S, Noubissi FK, Ray P, Kumar S. Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy. J Exp Pharmacol 2021;13:303-28. [PMID: 33776489 DOI: 10.2147/JEP.S267383] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
34 Hung CC, Chien CY, Chu PY, Wu YJ, Lin CS, Huang CJ, Chan LP, Wang YY, Yuan SF, Hour TC, Chen JY. Differential resistance to platinum-based drugs and 5-fluorouracil in p22phox-overexpressing oral squamous cell carcinoma: Implications of alternative treatment strategies. Head Neck 2017;39:1621-30. [PMID: 28498554 DOI: 10.1002/hed.24803] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
35 Kikkawa YS, Nakagawa T, Taniguchi M, Ito J. Hydrogen protects auditory hair cells from cisplatin-induced free radicals. Neurosci Lett. 2014;579:125-129. [PMID: 25064701 DOI: 10.1016/j.neulet.2014.07.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
36 Jie H, Tao S, Liu L, Xia L, Charko A, Yu Z, Bance M, Yin S, Robertson GS, Wang J. Cochlear protection against cisplatin by viral transfection of X-linked inhibitor of apoptosis protein across round window membrane. Gene Ther 2015;22:546-52. [PMID: 25809464 DOI: 10.1038/gt.2015.22] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
37 Fetoni AR, Paciello F, Mezzogori D, Rolesi R, Eramo SL, Paludetti G, Troiani D. Molecular targets for anticancer redox chemotherapy and cisplatin-induced ototoxicity: the role of curcumin on pSTAT3 and Nrf-2 signalling. Br J Cancer 2015;113:1434-44. [PMID: 26469832 DOI: 10.1038/bjc.2015.359] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 10.5] [Reference Citation Analysis]
38 Ma W, Li J, Hu J, Cheng Y, Wang J, Zhang X, Xu M. miR214-regulated p53-NOX4/p66shc pathway plays a crucial role in the protective effect of Ginkgolide B against cisplatin-induced cytotoxicity in HEI-OC1 cells. Chemico-Biological Interactions 2016;245:72-81. [DOI: 10.1016/j.cbi.2016.01.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
39 Wang L, Wu W, Zhu X, Ng W, Gong C, Yao C, Ni Z, Yan X, Fang C, Zhu S. The Ancient Chinese Decoction Yu-Ping-Feng Suppresses Orthotopic Lewis Lung Cancer Tumor Growth Through Increasing M1 Macrophage Polarization and CD4+ T Cell Cytotoxicity. Front Pharmacol 2019;10:1333. [PMID: 31780946 DOI: 10.3389/fphar.2019.01333] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
40 Laurell G, Videhult Pierre P. Hearing Loss After Cisplatin: Oxidative Stress Pathways and Potential for Protection. In: Miller J, Le Prell CG, Rybak L, editors. Free Radicals in ENT Pathology. Cham: Springer International Publishing; 2015. pp. 217-41. [DOI: 10.1007/978-3-319-13473-4_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Kros CJ, Steyger PS. Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies. Cold Spring Harb Perspect Med 2019;9:a033548. [PMID: 30559254 DOI: 10.1101/cshperspect.a033548] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 12.0] [Reference Citation Analysis]
42 Gunewardene N. Adenosine amine congener ameliorates cisplatin-induced hearing loss. WJO 2013;3:100. [DOI: 10.5319/wjo.v3.i3.100] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Ahmedova A, Mihaylova R, Momekova D, Shestakova P, Stoykova S, Zaharieva J, Yamashina M, Momekov G, Akita M, Yoshizawa M. M 2 L 4 coordination capsules with tunable anticancer activity upon guest encapsulation. Dalton Trans 2016;45:13214-21. [DOI: 10.1039/c6dt01801g] [Cited by in Crossref: 34] [Cited by in F6Publishing: 9] [Article Influence: 6.8] [Reference Citation Analysis]
44 Fetoni AR, Eramo SL, Paciello F, Rolesi R, Podda MV, Troiani D, Paludetti G. Curcuma longa (curcumin) decreases in vivo cisplatin-induced ototoxicity through heme oxygenase-1 induction. Otol Neurotol 2014;35:e169-77. [PMID: 24608370 DOI: 10.1097/MAO.0000000000000302] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]